These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8243561)

  • 21. Lisuride reduces intravenous cocaine self-administration in rats.
    Pulvirenti L; Koob GF
    Pharmacol Biochem Behav; 1994 Apr; 47(4):819-22. PubMed ID: 8029249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2000 Jun; 398(2):259-62. PubMed ID: 10854838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-dependent interactions between iboga agents and cocaine.
    Maisonneuve IM; Visker KE; Mann GL; Bandarage UK; Kuehne ME; Glick SD
    Eur J Pharmacol; 1997 Oct; 336(2-3):123-6. PubMed ID: 9384223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.
    Maisonneuve IM; Rossman KL; Keller RW; Glick SD
    Brain Res; 1992 Mar; 575(1):69-73. PubMed ID: 1504783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments.
    Alburges ME; Ramos BP; Bush L; Hanson GR
    Eur J Pharmacol; 2000 Feb; 390(1-2):119-26. PubMed ID: 10708715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors.
    Sershen H; Hashim A; Lajtha A
    Brain Res Bull; 1997; 42(3):161-8. PubMed ID: 8995326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A slow-onset, long-duration indanamine monoamine reuptake inhibitor as a potential maintenance pharmacotherapy for psychostimulant abuse: effects in laboratory rat models relating to addiction.
    Gardner EL; Liu X; Paredes W; Giordano A; Spector J; Lepore M; Wu KM; Froimowitz M
    Neuropharmacology; 2006 Oct; 51(5):993-1003. PubMed ID: 16901516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in gene expression and signal transduction following ibogaine treatment.
    Onaivi ES; Akinshola BE; Ali SF
    Alkaloids Chem Biol; 2001; 56():135-53. PubMed ID: 11705105
    [No Abstract]   [Full Text] [Related]  

  • 29. Ibogaine in the treatment of substance dependence.
    Brown TK
    Curr Drug Abuse Rev; 2013 Mar; 6(1):3-16. PubMed ID: 23627782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization.
    Szumlinski KK; McCafferty CA; Maisonneuve IM; Glick SD
    Brain Res; 2000 Jul; 871(2):245-58. PubMed ID: 10899291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
    Paterson NE; Markou A
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].
    Kazlauskas S; Kontrimaviciūte V; Sveikata A
    Medicina (Kaunas); 2004; 40(3):216-9. PubMed ID: 15064541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine.
    Glick SD; Maisonneuve IM; Pearl SM
    Brain Res; 1997 Feb; 749(2):340-3. PubMed ID: 9138735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of Antiaddictive Actions of Ibogaine
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 1998 May; 844(1):214-226. PubMed ID: 29090809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cocaine self-administration in Wistar-Kyoto rats: a behavioral and biochemical analysis.
    Jastrzębska J; Frankowska M; Szumiec Ł; Sadakierska-Chudy A; Haduch A; Smaga I; Bystrowska B; Daniel WA; Filip M
    Behav Brain Res; 2015 Oct; 293():62-73. PubMed ID: 26192911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats.
    Przegaliński E; Gołda A; Frankowska M; Zaniewska M; Filip M
    Eur J Pharmacol; 2007 Mar; 559(2-3):165-72. PubMed ID: 17291490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral and neurochemical responses to cocaine in periadolescent and adult rats.
    Frantz KJ; O'Dell LE; Parsons LH
    Neuropsychopharmacology; 2007 Mar; 32(3):625-37. PubMed ID: 16794567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strain differences in patterns of drug-intake during prolonged access to cocaine self-administration.
    Freeman KB; Kearns DN; Kohut SJ; Riley AL
    Behav Neurosci; 2009 Feb; 123(1):156-64. PubMed ID: 19170440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides.
    Cappendijk SL; Hurd YL; Nylander I; van Ree JM; Terenius L
    Eur J Pharmacol; 1999 Jan; 365(2-3):175-82. PubMed ID: 9988100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats.
    Koeltzow TE; Vezina P
    Behav Brain Res; 2005 May; 160(2):250-9. PubMed ID: 15863221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.